Insulet Corp. (PODD) EPS Basic: 4.30
Is Insulet Corp.’s EPS basic high or low?
Insulet Corp.'s EPS basic of 4.30 is 101% above its 5-year average of 2.14, near the high end of its 5-year range (0.07–5.97).
9.28% below its 12-month average of 4.74.
PODD Annual EPS Basic Chart
Annual fiscal-year basic EPS history; no daily interpolation.
PODD Average EPS Basic Chart
PODD Current vs Average EPS Basic Chart
PODD EPS Basic Metrics
EPS BASIC
4.30
EPS BASIC AVG TTM
4.74
EPS BASIC AVG 3Y
3.13
EPS BASIC AVG 5Y
2.14
EPS BASIC AVG 10Y
0.99
EPS BASIC AVG 15Y
-0.55
EPS BASIC AVG 20Y
-1.03
CURRENT VS TTM AVG
-9.28%
CURRENT VS 3Y AVG
+37.53%
CURRENT VS 5Y AVG
+100.52%
CURRENT VS 10Y AVG
+335.86%
CURRENT VS 15Y AVG
+877.71%
CURRENT VS 20Y AVG
+518.55%
Insulet Corp. EPS Basic Formula & Definition
EPS Basic is earnings per common share before the effect of potentially dilutive securities. It shows how much profit is attributable to each current common share.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Insulet Corp. EPS Basic FAQ
- What is the EPS basic for Insulet Corp. (PODD)?
- The EPS basic for PODD stock is 4.30.
- Is Insulet Corp.'s EPS basic high or low?
- Insulet Corp.'s EPS basic of 4.30 is 101% above its 5-year average of 2.14, near the high end of its 5-year range (0.07–5.97).
- What is the TTM average EPS basic for Insulet Corp. (PODD)?
- The TTM average EPS basic for PODD stock is 4.74.
- What is the 3Y average EPS basic for Insulet Corp. (PODD)?
- The 3Y average EPS basic for PODD stock is 3.13.
- What is the 5Y average EPS basic for Insulet Corp. (PODD)?
- The 5Y average EPS basic for PODD stock is 2.14.
- What is the 10Y average EPS basic for Insulet Corp. (PODD)?
- The 10Y average EPS basic for PODD stock is 0.99.
- What is the 15Y average EPS basic for Insulet Corp. (PODD)?
- The 15Y average EPS basic for PODD stock is -0.55.
- What is the 20Y average EPS basic for Insulet Corp. (PODD)?
- The 20Y average EPS basic for PODD stock is -1.03.
Insulet Corp. EPS Basic History
| DATE | EPS BASIC |
|---|---|
| 2025-12-31 | 3.51 |
| 2024-12-31 | 5.97 |
| 2023-12-31 | 2.96 |
| 2022-12-31 | 0.07 |
| 2021-12-31 | 0.25 |
| 2020-12-31 | 0.11 |
| 2019-12-31 | 0.19 |
| 2018-12-31 | 0.06 |
| 2017-12-31 | -0.46 |
| 2016-12-31 | -0.51 |
| 2015-12-31 | -1.29 |
| 2014-12-31 | -0.93 |
| 2013-12-31 | -0.83 |
| 2012-12-31 | -1.08 |
| 2011-12-31 | -1.22 |
| 2010-12-31 | -1.54 |
| 2009-12-31 | -2.68 |
| 2008-12-31 | -3.36 |
| 2007-12-31 | -3.21 |
| 2006-12-31 | -99.10 |
| 2005-12-31 | -70.95 |
| 2004-12-31 | -47.64 |
| 2003-12-31 | -43.88 |
| 2002-12-31 | -42.30 |
Related Metrics
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy